Objective: The aim of the present study was to evaluate the effect of magnetic stimulation on urodynamic stress incontinence refractory to pelvic floor muscle training in a randomized sham-controlled study.
| INTRODUCTION
Pelvic floor muscle training (PFMT) is the treatment of choice for stress urinary incontinence (SUI). The efficacy of PFMT for the treatment of SUI has been reported in several randomized controlled trials. 1, 2 Although improvements in SUI following PFMT have been reported to be in the order of 50%-70%, the cure rates are no greater than 15%-30%. 3 Surgical treatment, such as the urethral sling (tension-free vaginal tape or tension-free obturator tape), is effective, but these surgeries can cause adverse events such as bladder perforation, hemorrhage, tape exposure, and de novo urgency, 2, 4 and many patients may prefer non-surgical treatment. According to the Japanese guidelines for female lower urinary tract symptoms (LUTS), 2 PFMT is the treatment of choice, with surgical treatment is ranked as the second-line treatment option even though both treatments are graded as "Recommendation A."
Electrical stimulation (ES) has also been reported to be effective for SUI, but because of the pain or discomfort associated with the electrode, ES has not been used as a first-line treatment choice. [5] [6] [7] Magnetic stimulation (MS) was developed as a safe and noninvasive intervention for urgency incontinence and/or SUI as an alternative to ES. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The safety of MS has been reported in animal studies. 12, 13 Significant improvements following active rather than sham MS for the treatment of urgency incontinence have been reported in multicenter single-blind randomized sham-controlled studies. 15, 16 Furthermore, a reduction in the frequency of leakage and urodynamic improvement, including an increase in maximum urethral closure pressure, have been reported following MS in patients with SUI. 10, 14 Although the efficacy of MS for the treatment of SUI has been reported, few randomized sham-controlled studies have been conducted investigating the use of MS in the treatment of SUI. [17] [18] [19] [20] [21] Thus, the aim of the present randomized sham-controlled study was to evaluate the effects of MS on USI refractory to PFMT in women who did not want to undergo surgery.
| METHODS
Women with urodynamic SUI refractory to PFMT for more than 12 weeks and who did not want to undergo surgery were enrolled in the present study. Women with urgency urinary incontinence due to detrusor overactivity as determined by videourodynamic studies, those with complications after pelvic surgery or trauma, those wearing a pacemaker (an implanted-type cardiac defibrillator), those complicated by malignancy, those with a residual urine volume ≥200 mL, those deemed by the doctor in charge to be unsuitable for the present trial, and women who were pregnant or suspected of being pregnant were excluded from the present study. None of the patients in the present study had a history of incontinence surgery, such as Burch operation, colposuspension, or urethral sling, including tensionfree vaginal tape or tension-free obturator tape.
The study procedures were approved by the Institutional Review
Board of Dokkyo Medical University, and informed written consent was obtained from each patient before they entered the study. The study was conducted in accordance with the Declaration of Helsinki.
The stimulation device was an armchair-type of magnetic stimulator (Nihon Kohden, Tokyo, Japan; Figure 1 ). Urodynamic studies were performed before MS therapy (after PFMT), as well as after MS therapy. In the urodynamic studies, an 8- 
| Statistical analysis
Wilcoxon signed-rank tests were used for between-group comparisons and the Mann-Whitney U-test was used for intergroup comparisons. P < .05 was regarded as statistically significant.
| RESULTS
Thirty-nine patients were enrolled in the study, with 26 patients randomized to the active treatment group and 13 randomized to the sham group. Nine patients (8 in the active group, 1 in the sham group) dropped out of the study due to unknown reasons (n = 8) and moving away (n = 1). This left 18 patients in the active treatment group and 12 in the sham group who completed the study. There were no significant differences between the 2 groups with regard to baseline characteristics ( Table 2 ).
The number of incontinence episodes (times per week), the degree of incontinence in the 24-h pad test, and ICIQ-SF total and QOL scores decreased significantly after treatment compared with baseline in the active treatment group (all P < .05); there was no significant change from baseline in any of these parameters in the sham treatment group (Table 3) . ALPP increased significantly after treatment compared with the baseline in the active group (P < .01), but not in the sham group. There were significant intergroup differences in changes in ICIQ-SF total score (P < .05) and ALPP (P < .01) from baseline (Table 4) .
No side effects attributable to MS were noted through an oral questionnaire.
| DISCUSSION
ES has been reported to be effective for SUI, with reported success rates in the range 60%-70%. [5] [6] [7] 24 Pelvic floor ES has been reported to be safe, but has been associated with the occurrence of abdominal cramps, diarrhea, pain, bleeding, an uncomfortable feeling, and urinary tract infection. [5] [6] [7] The mechanism underlying the effects of ES on SUI may involve increased contractility of the pelvic floor muscles via a direct effect of the stimulation on muscle fibers and pudendal nerves. 5 In addition, a randomized sham-controlled study has reported that ES using an anal electrode is effective for the treatment of post-prostatectomy incontinence. 25 Although sacral nerve stimulation and percutaneous tibial nerve stimulation have been reported to be effective for the treatment of refractory overactive bladder (OAB)
or urgency incontinence, they have not been used for the treatment of SUI.
26,27
The conditions of ES and MS for SUI differ from those used to treat OAB: low frequencies (5-10 Hz) are thought desirable for the inhibition of detrusor contraction, whereas relatively high frequencies, ranging from 20 to 50 Hz, have been reported to be effective for urethral closure and contraction of pelvic floor muscles. 6, 7 Intermittent stimulation is also recommended in order to avoid muscle fatigue. Thus, in the present study we used a frequency of 50 Hz and a cycle of 5-s on/ 5-s off for the active treatment. In the present study, this stimulation protocol was used up to the maximum tolerable level for 20 min each week.
MS has been used as a safe and non-invasive alternative to ES for the treatment of urinary incontinence. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The mechanism of action of MS is considered to be the same as that of ES. MS is effective for the activation of deep proximal nerves, with little pain, that are difficult to activate with ES. The electrical current produced direct ES falls off as a function of the impedance of the tissue between the stimulating electrodes and the neural tissue. Skin, bone, and subcutaneous tissue have high impedance. Thus, it is necessary to deliver much higher electric currents to the skin to deliver sufficient electric current to neural tissue, thereby activating pain receptors. However, the magnetic field penetrates all body tissues without alteration, falling off in magnitude only as the inverse square of the distance.
Therefore, for the same current generated at the level of the neural tissue, the current generated at the skin using MS will be less than that used for ES. 9 Furthermore, patients do not need undress Data are given as the mean AE SD. P-values were determined using the Mann-Whitney U-test.
a The degree of incontinence was determined using a 24-h pad test.
because the magnetic field passes through clothing. MS can be applied both at the sacral root 17 and in the pelvic floor region. However, it is difficult to fix the coil for a long time for the former, and the commercially available stimulator is usually a chair-type stimulator that stimulates the pelvic floor ( Figure 1) . 15, 16, [18] [19] [20] [21] Some previous non-randomized studies have reported on the use of MS for SUI. 10, 11 In another study, Yokoyama et al. 18 compared the effects of ES, MS, and PFMT in 36 men with severe urinary incontinence after radical prostatectomy and found that both MS and ES achieved higher continence rates at 1 and 3 months compared with PFMT, but the average 24-h leakage was <10 g in all groups after 6 months.
There have been few sham-controlled randomized studies of MS for the treatment of urodynamic SUI. The present study was a pilot study comparing the effects of active and sham MS. Although the number of subjects in the present study was small, only refractory patients were included in the study and outcomes were evaluated objectively using the pad test and urodynamic investigations. In the active treatment group, the number of incontinence episodes, the degree of incontinence (pad test), ICIQ-SF scores, and ALPP were all significantly improved at 10 weeks after treatment. These results may suggest that MS is effective for urodynamic SUI. In terms of the safety of MS, none of the patients experienced any device-related adverse events.
It may be difficult to blind patients with regard to active versus sham stimulation. In the present study, the sham device was set to stimulate very weakly so that patients perceived some stimulation.
Therefore, a placebo effect or the effect of low-intensity stimulation may have contributed to some of the improvements or had an additive effect to PFMT in the sham stimulation group.
It may be better to investigate the effects of MS without PFMT. A limitation of the present study is its small sample size (n = 39) and insufficient statistical power, because this study was designed as a pilot study. Thus, we could not prove the between-group differences with regard to the number of leaks and the amount of leakage in the pad test (Table 4) . If patients are treated more frequently (e.g. 2 or 3 times a week), the cure rate may be increased. However, it was very difficult to recruit patients and treat patients frequently and then to divide patients between the active and sham treatment Data are given as the mean AE SD. P-values were determined using the Wilcoxon matched-pairs signed-ranks test.
a The degree of incontinence was determined using a 24-h pad test. Data are given as the mean change from baseline AE SD. P-values were determined using the Mann-Whitney U-test.
groups. Therefore, the findings of the present study show only the short-term effects of MS and do not show the durability of treatment efficacy after treatment is discontinued. Further randomized controlled studies with a large sample size are needed in the future.
| Conclusions
Although the sample size in the present study was small, active MS treatment had significant effects, whereas sham MS treatment did not have any effects on urodynamic SUI. MS appeared to be a safe and useful therapy for urodynamic SUI, and it may be an effective alternative to ES. Further randomized controlled studies with a large sample size are needed to confirm the efficacy of the MS for the treatment of SUI.
